Pharma

Your Article Summary

See Latest Articles

Allos Therapeutics to Present at the 4th Annual Citi Biotech Day
Allos Therapeutics, 03/27/09

Allos Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, announced that members of the Company's senior management will present a corporate overview on Wednesday, April at the 4th Annual Citi Biotech Day Conference in New York City.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09

Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09

Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09

 See all of Biotechnology

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

KLAS Ranks PACS Products
HealthDataManagement, 12/11/09

Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas Wednesday, December 9
Repligen, 12/09/09

Allos Therapeutics' FOLOTYN Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant
Allos Therapeutics, 12/08/09

 See all of Conferences/Meetings